Delegate With Leukemia: Cancer-Survivor Governor Should Sign Sick Leave Bill

BALTIMORE (WJZ) -- Governor Larry Hogan will be signing new bills into law Thursday, and supporters of paid sick leave are hoping theirs is one of them.

Paid sick leave was one of the hottest topics in the General Assembly session this year, and supporters are still working to see it through.

The bill would provide one hour of sick leave for every 30 hours an employee works. That's at least five paid sick days for workers in companies with 15 or more employees, and unpaid leave from companies with less than 15 employees.

When Hogan was asked about it on the last day of session, he wasn't sure he'd sign it.

"This one they will send to us with about 1,000 other bills and we'll have until May sometime to decide what to do with all of them," he said.

It's now May 2 and supporters want to know what lies ahead for the legislation.

Baltimore City delegate Luke Clippinger was joined by others in Annapolis today, urging the governor to sign.

"He had his own challenges with cancer, he sent me a very kind note saying we both have overcome and are overcoming this very difficult disease," says Clippinger, who suffers from leukemia. "If it was good enough for the both of us to have sick leave, it's good enough for over 700,000 Marylanders."

The governor proposed his own sick day bill bu the General Assembly rejected it.

He initially said he would veto the bill due to the potential impact on small businesses, but later said he'd review it.

Supporters hope he'll at least let it become law without his signature.

Besides Thursday's, there is at least one more bill signing before the end of the month.

Follow @CBSBaltimore on Twitter and like WJZ-TV | CBS Baltimore on Facebook

Read more
f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.